Dakshidin Corporatio
Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its n… Read more
Dakshidin Corporatio (DKSC) - Net Assets
Latest net assets as of September 2024: $6.79K USD
Based on the latest financial reports, Dakshidin Corporatio (DKSC) has net assets worth $6.79K USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($415.47K) and total liabilities ($408.67K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.79K |
| % of Total Assets | 1.64% |
| Annual Growth Rate | -34.05% |
| 5-Year Change | -96.45% |
| 10-Year Change | -94.47% |
| Growth Volatility | 155.46 |
Dakshidin Corporatio - Net Assets Trend (2016–2024)
This chart illustrates how Dakshidin Corporatio's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Dakshidin Corporatio (2016–2024)
The table below shows the annual net assets of Dakshidin Corporatio from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | $6.79K | 0.00% |
| 2023-12-31 | $6.79K | -72.29% |
| 2023-03-31 | $24.51K | 0.00% |
| 2022-12-31 | $24.51K | -87.21% |
| 2022-03-31 | $191.61K | 0.00% |
| 2021-12-31 | $191.61K | +35.15% |
| 2021-03-31 | $141.78K | 0.00% |
| 2020-12-31 | $141.78K | +502.56% |
| 2019-12-31 | $23.53K | -80.85% |
| 2018-12-31 | $122.88K | -9.98% |
| 2017-12-31 | $136.50K | -1.66% |
| 2016-12-31 | $138.81K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Dakshidin Corporatio's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 85750600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.91 Million | 42770.60% |
| Total Equity | $6.79K | 100.00% |
Dakshidin Corporatio Competitors by Market Cap
The table below lists competitors of Dakshidin Corporatio ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SMART PRODUCTS NIGERIA PLC
XNSA:SMURFIT
|
$4.21 |
|
Adams Plc
LSE:ADA
|
$4.21 |
|
SEEEN PLC
LSE:SEEN
|
$4.40 |
|
Coal Asia Holdings Inc
PSE:COAL
|
$4.43 |
|
Tytan Holdings Inc
PINK:TYTN
|
$3.97 |
|
RCABS Inc
PINK:AXXA
|
$3.94 |
|
Calissio Resources Group Inc
PINK:CRGP
|
$3.94 |
|
Axis Technologies Group Inc
PINK:AXTG
|
$3.94 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dakshidin Corporatio's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,793 to 6,793, a change of 0 (0.0%).
- Net loss of 17,720 reduced equity.
- Other factors increased equity by 17,720.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-17.72K | -260.86% |
| Other Changes | $17.72K | +260.86% |
| Total Change | $- | 0.00% |
Book Value vs Market Value Analysis
This analysis compares Dakshidin Corporatio's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 196.66x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $0.00 | $0.00 | x |
| 2016-12-31 | $0.00 | $0.00 | x |
| 2017-12-31 | $0.00 | $0.00 | x |
| 2018-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-03-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-03-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-03-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
| 2024-03-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dakshidin Corporatio utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -260.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 61.16x
- Recent ROE (-260.86%) is below the historical average (-194.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.12K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.58K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-131.41K |
| 2016 | -1.58% | 0.00% | 0.00x | 2.59x | $-16.08K |
| 2017 | -1.69% | 0.00% | 0.00x | 2.63x | $-15.95K |
| 2018 | -11.09% | 0.00% | 0.00x | 2.93x | $-25.91K |
| 2019 | -779.45% | -961.85% | 0.04x | 20.91x | $-185.75K |
| 2020 | -5.56% | -3.78% | 0.42x | 3.49x | $-22.06K |
| 2021 | -5.56% | -3.78% | 0.42x | 3.49x | $-22.06K |
| 2021 | -113.17% | -8743.43% | 0.00x | 3.26x | $-236.00K |
| 2022 | -113.17% | -8743.43% | 0.00x | 3.26x | $-236.00K |
| 2022 | -681.64% | 0.00% | 0.00x | 21.71x | $-169.54K |
| 2023 | -681.64% | 0.00% | 0.00x | 21.71x | $-169.54K |
| 2023 | -260.86% | 0.00% | 0.00x | 61.16x | $-18.40K |
| 2024 | -260.86% | 0.00% | 0.00x | 61.16x | $-18.40K |
Industry Comparison
This section compares Dakshidin Corporatio's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dakshidin Corporatio (DKSC) | $6.79K | 0.00% | 60.16x | $3.97 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |